1. EP-1110: Combination of RT and cetuximab for aggressive, high-risk CSCC of h&n: a propensity score analysis. (April 2016) Authors: Raben, A.; Palmer, J.D.; Strasser, J.; Hanlon, A.; Dzeda, M.; Hockstein, N.; Schneider, C.J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Vapor products exposure and risk assessment assumption refinement: Ingredient transfer. (16th September 2016) Authors: Theophilus, E.H.; Strasser, J.; Szabo, D.; Culbert, C.; Moldoveanu, S. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗